TV 목록 보기
증권
지난 주요뉴스 한국경제TV에서 선정한 지난 주요뉴스 뉴스썸 한국경제TV 웹사이트에서 접속자들이 많이 본 뉴스 한국경제TV 기사만 onoff
[PRNewswire] 새 멤브레인 생산 공장의 상량식을 축하한 Merck 2020-10-09 10:16:02
[PRNewswire] 새 멤브레인 생산 공장의 상량식을 축하한 Merck - 무균 필터용 멤브레인 제조설비가 성장하는 바이오의약품 시장의 고객 수요 충족에 도움이 될 것 - 1억 4천만 유로 이상의 투자로 약 55개의 신규 일자리 창출 - 2022년 완공 예정 (다름슈타트, 독일 2020년 10월 8일 PRNewswire=연합뉴스) 과학기술 분야의...
[PRNewswire] Merck Announces Out-Licensing Agreement for Phase II-ready 2020-10-06 21:25:23
of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. Logo: https://mma.prnewswire.com/media/1136775/Merck_Logo.jpg Merck Logo Your Contacts Media Relations Friederike.segeberg@merckgroup.com Phone: +49 151 1454 6328 Investor Relations...
[PRNewswire] Merck Advances Oncology Portfolio and Pipeline with New and 2020-09-14 09:43:33
global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. Contact: Julissa.Viana@emdserono.com Phone: +1 (781) 206 5795 Logo...
[PRNewswire] New MAVENCLAD(R) Data at ACTRIMS-ECTRIMS MSVirtual2020 Meeting 2020-09-11 21:05:05
the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. (Logo: https://mma.prnewswire.com/media/1136775/Merck_Logo.jpg) Merck Logo Contact:...
[PRNewswire] Merck Announces Positive Phase II Results for Investigational 2020-09-10 21:08:46
to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. (Logo: https://mma.prnewswire.com/media/1136775/Merck_Logo.jpg) Merck Logo For...
[PRNewswire] 머크, 5천900만 유로 투자로 항체 의약품 포합 물질 제조 시설 확장 2020-09-10 00:43:52
- https://mma.prnewswire.com/media/1250213/Merck_ADC_Expansion.jpg Merck is expanding its ADC manufacturing capabilities. ADCs are an emerging class of medicines designed for high-specificity targeting and destruction of cancer cells, while preserving healthy ones. Source: Merck [편집자 주] 본고는...
[PRNewswire] Merck to Showcase New Data at ACTRIMS-ECTRIMS ... (2/2) 2020-09-04 01:02:52
global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. Contact tone-brauti.fritzen@merckgroup.com +49 151 1454 2694 Logo...
[PRNewswire] Merck to Showcase New Data at ACTRIMS-ECTRIMS ... (1/2) 2020-09-04 01:02:43
3, 2020 PRNewswire=연합뉴스) Merck, a leading science and technology company, today announced it will present data on its approved and investigational multiple sclerosis (MS) treatments at MSVirtual2020: 8th Joint ACTRIMS-ECTRIMS Meeting. Merck will present 54 abstracts at the meeting, taking place...
[PRNewswire] 머크, 상하이에 동사 최대의 M랩(M Lab™) 협업센터 오픈 2020-07-10 15:14:15
solutions, validation services, training and hands-on applications -- Shanghai center is newest and largest addition to Merck's global network of nine M Lab™ Collaboration Centers DARMSTADT, Germany, July 10, 2020 /PRNewswire/ -- Merck, a leading science and technology company, opened its M...
[PRNewswire] 칼립소바이오테크, CALY-002의 임상용 배치 제조를 완료 2020-06-18 20:44:46
[PRNewswire] 칼립소바이오테크, CALY-002의 임상용 배치 제조를 완료 -- AGC바이오로직스는 IL-15를 표적으로 하는 인간 단일 클론 항체를 생산 (시애틀 2020년 6월 18일 PRNewswire=연합뉴스) 세계적인 바이오 의약품 계약 개발 제조 조직(CDMO) AGC바이오로직스(AGC Biologics)[ http://www.agcbio.com/ ]는...
TV 목록 보기
증권
